Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Enhancing Tregs can protect against alopecia areata.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

YAP and TAZ proteins control skin cell growth and repair.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.